Ueda Maya
BioSafety Research Center Inc. (BSRC), Shizuoka, Japan.
Methods Mol Biol. 2020;2119:73-78. doi: 10.1007/978-1-0716-0323-9_6.
DNA damage detected by the in vivo comet assay is an initial factor for Clastogenicity and gene mutation, and it is considered that the potential for carcinogenesis can be evaluated. However, there is a problem that the test results were not stable because the results fluctuated largely depending on the test execution conditions. Therefore, the Organisation for Economic Co-operation and Development (OECD) test guideline have described the conditions under which tests should be conducted in order to obtain stable data. Herein, I describe an in vivo comet assay that is based on recently approved the OECD test guideline (TG 489).
通过体内彗星试验检测到的DNA损伤是致染色体断裂性和基因突变的初始因素,并且认为可以评估致癌潜力。然而,存在一个问题,即测试结果不稳定,因为结果很大程度上取决于测试执行条件而波动。因此,经济合作与发展组织(OECD)测试指南描述了为获得稳定数据而应进行测试的条件。在此,我描述了一种基于最近批准的OECD测试指南(TG 489)的体内彗星试验。